Full name
GRUPER 2 SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
49.41.Z - Road freight transport
68.20.Z - Rental and management of own or leased real estate
73.11.Z - Advertising agency activities
86.90.D - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 2,7 | -50,7 | -0,8 | 98,4 |
EBITDA | 2,6 | -50,9 | 4,1 | 108,1 |
Short time liabilities | 1,1 | 32,7 | 40,5 | 23,7 |
Equity capital | 20,9 | -20,3 | -26,1 | -28,9 |
Operating profit (EBIT) | 2,6 | -50,9 | 4,1 | 108,1 |
Assets | 22 | 12,4 | 14,3 | 15,3 |
Net profit (loss) | 2,5 | -41,1 | -5,8 | 85,8 |
Cash | 19,9 | 0 | 0 | 0 |
Net income from sale | 9,6 | 9,6 | 87,4 | 810,4 |
Liabilities and provisions for liabilities | 1,1 | 32,7 | 40,5 | 23,7 |
Working assets | 20 | 0,8 | 7,8 | 875 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 11,8 | 203 | 22,4 | -180,6 |
Equity capital to total assets | 95 | -162,9 | -182 | -19,1 |
Gross profit margin | 28,3 | -528,4 | -0,9 | 527,5 |
EBITDA Margin | 27,5 | -530,1 | 4,7 | 534,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 42 | 1243 | 169 | -1074 |
Current financial liquidity indicator | 18.163726806640625 | 0.024461226537823677 | 0.19276519119739532 | 0,2 |
Net dept to EBITDA | -7.550656318664551 | -0.5975574254989624 | 8.134315490722656 | 8,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane